Future of Metabolic Endoscopy

Abstract

Obesity has been escalating as one of the worst public health epidemics. Conservative therapies including lifestyle modifications and weight loss medications have limited efficacy and long-term sustainability. Bariatric surgeries, although effective, remain underutilized due to their cost, safety concerns, and patient acceptance. In the past two decades, endoscopic bariatric and metabolic therapies (EBMTs) have emerged as safe, effective, and less invasive options for the treatment of obesity and its comorbidities, with recent studies reporting favorable outcomes in terms of weight loss and metabolic parameters. This article reviews the major and newly developed EBMTs, with emphasis on their metabolic effects and potential use in the management of metabolic conditions.

Keywords

• endoscopic bariatric and metabolic therapies (ebmt)
• endoscopic obesity
• endoscopic sleeve gastroplasty (esg)
• intragastric balloons (igb)
• metabolic endoscopy
• primary obesity surgery endoluminal (pose)